FET
Glucose Metabolism
Rigshospitalet, DenmarkSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Glucose Metabolism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin SINA Health Education and Welfare Trust | Phase 4 | BBB |
ZIDOVUDINE Kirby Institute | Phase 4 | BB |
Empagliflozin SINA Health Education and Welfare Trust | Phase 4 | BB |
Exenatide RenJi Hospital | Phase 4 | BB |
Glargine Federico II University | Phase 4 | BB |
View all 28 →
Same molecule, other indications
FET is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →